Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GALT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IL11RA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIGMAR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCL27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC730098 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DCTN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPP25L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCL19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCL21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNTFR-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNTFR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM205BP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENHO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on